Mbiomics competitive analysis

Explore patent oppositions filed by Mbiomics against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 15, 2026
Patent NumberTitleApplicantOpposition Date
Methods For Diagnosing A Cancer- Or Antibiotics-Induced Dysbiosis And Their Use For Improving Cancer Treatment By ImmunotherapyEVERIMMUNEOct 14, 2026

Latest PTAB cases involving Mbiomics

Discover the latest PTAB cases involving Mbiomics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Mbiomics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 15, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MBIOMICS1 - - -
EVERIMMUNE - 1 - -
INSTITUT GUSTAVE ROUSSY - 2 - -
INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALE INSERM - 12 - -